Home>
US Stocks>
Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd share price today

(ENLV)

Enlivex Therapeutics Ltd share price is $1.3 & ₹110.09

$1.3

▲

0.22

(20.37%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Enlivex Therapeutics Ltd share price in Dollar and Rupees. Guide to invest in Enlivex Therapeutics Ltd from India. Also see the sentimental analysis on Indian investors investing in Enlivex Therapeutics Ltd. Get details on the Indian mutual funds that are investing in Enlivex Therapeutics Ltd. Get Analyst recommendations and forecasts along with all the Enlivex Therapeutics Ltd's financials.

Enlivex Therapeutics Ltd share price movements

$1.13
$1.31
$1.30
13.08%
Downside
Day's Volatility :13.41%
Upside
0.38%
$0.81
$4.59
$1.30
37.68%
Downside
52 Weeks Volatility :82.35%
Upside
71.68%

Enlivex Therapeutics Ltd Returns

Period	Enlivex Therapeutics Ltd	Index (Russel 2000)
3 Months	-12.2%	0.0%
6 Months	-16.28%	0.0%
1 Year	-38.64%	0.0%
3 Years	-84.0%	-18.1%

Enlivex Therapeutics Ltd Key Statistics

in dollars & INR

Market Capitalization	$24.4M
Revenue TTM	$0.0
EBITDA	$-17.9M
Earnings Per Share (EPS)	$-0.98
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-61.17%

How to invest in Enlivex Therapeutics Ltd from India?

It is very easy for Indian residents to invest directly in Enlivex Therapeutics Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enlivex Therapeutics Ltd stock in both rupees (INR) and dollars (USD). Search for Enlivex Therapeutics Ltd or ENLV on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enlivex Therapeutics Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enlivex Therapeutics Ltd shares which would translate to 0.651 fractional shares of Enlivex Therapeutics Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Enlivex Therapeutics Ltd

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Enlivex Therapeutics Ltd on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 0% more investors are searching Enlivex Therapeutics Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Enlivex Therapeutics Ltd

Armistice Capital, LLC
9.73%
Morgan Stanley - Brokerage Accounts
1.12%
Renaissance Technologies Corp
0.34%
Sigma Investment Counselors Inc
0.14%
XTX Topco Ltd
0.10%
Goldman Sachs Group Inc
0.06%

Analyst Recommendation on Enlivex Therapeutics Ltd

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Enlivex Therapeutics Ltd(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Enlivex Therapeutics Ltd

What analysts predicted

Upside of 630.77%

Current:

$1.30

Target:

$9.50

Insights on Enlivex Therapeutics Ltd

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 87.6%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 131.0%

Enlivex Therapeutics Ltd Technicals Summary

Sell

Neutral

Buy

Enlivex Therapeutics Ltd is currently in a neutral trading position according to technical analysis indicators.

Enlivex Therapeutics Ltd Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Enlivex Therapeutics Ltd	-16.92%	-16.28%	-38.64%	-84.0%	-86.31%
Regeneron Pharmaceuticals, Inc.	-8.02%	-24.21%	-7.13%	21.97%	104.79%
Biontech Se	7.55%	14.34%	18.7%	-58.12%	380.92%
Alnylam Pharmaceuticals, Inc.	-6.28%	66.39%	48.51%	42.94%	104.44%
Vertex Pharmaceuticals Incorporated	-1.5%	-3.58%	31.51%	127.12%	108.61%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Enlivex Therapeutics Ltd	NA	NA	NA	-0.67	-0.61	-0.27	NA	1.62
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Enlivex Therapeutics Ltd	Buy	$24.4M	-86.31%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	104.79%	18.55	33.61%
Biontech Se	Buy	$28.9B	380.92%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	104.44%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	108.61%	32.84	-4.51%

About Enlivex Therapeutics Ltd

enlivex therapeutics ltd., a clinical stage immunotherapy company, engages in developing allogeneic drugs for immune system rebalancing. its product candidate is allocetra, an immunotherapy candidate, which is in phase iib clinical trial in patients with severe sepsis; that is in investigator-initiated phase ii clinical trial for the treatment of covid-19 patients in severe and critical conditions; and which is in phase iia clinical trial for the prevention of graft versus host disease in allogeneic hematopoietic stem cell transplants (hsct) patients. the company is also developing allocetra for the prevention of complications associated with bone marrow transplantations and/or hsct, and acute multiple organ failure. it also intends to develop its cell-based therapy to be combined with treatments of solid tumors via immune checkpoint rebalancing to enhance the efficacy of various anti-cancer therapies, including chimeric antigen receptor t-cell therapy and therapies targeting t-cell re

Organization	Enlivex Therapeutics Ltd
Employees	0
CEO	Mr. Shai Novik M.B.A.
Industry	Biotechnology

Important FAQs about investing in Enlivex Therapeutics Ltd from India :

What is Enlivex Therapeutics Ltd share price today?

Enlivex Therapeutics Ltd (ENLV) share price today is $1.30.

Can Indians buy Enlivex Therapeutics Ltd shares?

Yes, Indians can invest in the Enlivex Therapeutics Ltd (ENLV) from India.

With INDmoney, you can buy Enlivex Therapeutics Ltd at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Enlivex Therapeutics Ltd at zero transaction cost.

How can I buy Enlivex Therapeutics Ltd shares from India?

It is very easy to buy Enlivex Therapeutics Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enlivex Therapeutics Ltd be purchased?

Yes, you can buy fractional shares of Enlivex Therapeutics Ltd with INDmoney app.

What are the documents required to start investing in Enlivex Therapeutics Ltd stocks?

To start investing in Enlivex Therapeutics Ltd, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.